Windlas Biotech Limited announced the re-appointment of three key individuals to its board of directors. The Board, at its meeting held on February 5, 2026, approved the re-appointments based on the recommendation of the Nomination and Remuneration Committee, subject to shareholder approval. Mr. Ashok Kumar Windlass has been re-appointed as a Whole-time Director for a term of five years, effective May 3, 2026, through May 2, 2031. Mr. Windlass, a promoter and founder, brings over 56 years of experience in the manufacturing and pharmaceutical industries and has been instrumental in the company's growth. Additionally, Mr. Vivek Dhariwal and Mr. Gaurav Gulati have both been re-appointed as Non-executive Independent Directors for a second term of five years each. Their re-appointments are effective from May 6, 2026, up to May 5, 2031. Mr. Dhariwal has over 24 years of experience in manufacturing and supply chain operations, while Mr. Gulati brings expertise in business strategy and operations from his previous roles. These re-appointments are in line with regulatory requirements and aim to ensure continued leadership and governance within the company.